References
- Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–1933.
- Shimizu H, Annaberdyev S, Motamarry I, et al. Revisional bariatric surgery for unsuccessful weight loss and complications. Obes Surg. 2013;23(11):1766–1773.
- Odom J, Zalesin KC, Washington TL, et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg. 2010;20(3):349–356.,
- Zilberstein B, Pajecki D, De Brito ACG, et al. Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight. Obes Surg. 2004;14(6):802–805.
- Effective Public Health Practice Project, Quality assessment tool for quantitative studies. Eff Public Heal Pract Proj. 2003; 2–5.
- Thomas BH, Ciliska D, Dobbins M, et al. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldv Evid-Based Nu. 2004;1(3):176–184.
- Stanford FC, Toth AT, Shukla AP, et al. Weight loss medications in older adults after bariatric surgery for weight regain or inadequate weight loss: a multicenter study. Bariatr Surg Pract P. 2018;13(4):171–178.
- Toth A, Gomez G, Shukla A, et al. Weight loss medications in young adults after bariatric surgery for weight regain or inadequate weight loss: a Multi-Center study. Children. 2018;5(9):116.
- Stanford FC, Alfaris N, Gomez G, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study. Surg Obes Relat Dis. 2017;13(3):491–500.
- Srivastava G, Buffington C. A specialized medical management program to address Post-operative weight regain in bariatric patients. Obes Surg. 2018;28(8):2241–2246.
- Jester L, Wittgrove AC, Clark GW. Adjunctive use of appetite suppressant medications for improved weight management in bariatric surgical patients. Obes Surg. 1996;6(5):412–415.
- Pajecki D, Halpern A, Cercato C, et al. Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery. Rev Col Bras Cir. 2013;40(3):191–195.
- Nor Hanipah Z, Nasr EC, Bucak E, et al. Efficacy of adjuvant weight loss medication after bariatric surgery. Surg Obes Relat Dis. 2018;14(1):93–98.
- Rye P, Modi R, Cawsey S, et al. Efficacy of High-Dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. OBES SURG. 2018;28(11):3553–3558.
- Gorgojo-Martínez JJ, Feo-Ortega G, Serrano-Moreno C. Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery. Surg Obes Relat Dis. 2016;12(10):1856–1863.
- Schwartz J, Suzo A, Wehr AM, et al. Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review. Obes Surg. 2016;26(2):452–458.,
- Zoss I, Piec G, Horber FF. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band. Obes Surg. 2002;12(1):113–117.
- Guerdjikova AI, Kotwal R, McElroy SL. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery. Obes Surg. 2005;15(2):273–277.
- Miras AD, Pérez-Pevida B, Aldhwayan M, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endo. 2019;7(7):549–559.
- Franco JVA, Ruiz PA, Palermo M, et al. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, roux-en-y gastric bypass and adjustable gastric banding. Obes Surg. 2011;21(9):1458–1468.
- GlaxoSmithKline, Product monograph, Prod. Monogr. 2015;1–63.
- Novo Nordisk, Saxenda Product Monograph, 2016.
- Roche, Xenical Product Monograph, 2015.
- Sanofi-Aventis, Prescribing Information: Ionamin (Phentermine as a Resin Complex) 15 mg and 30 mg Capsules, 2006. pp. 1–6.